Varlilumab是一種單克隆抗體,設計用于實體瘤和血液惡性腫瘤的免疫治療。它是一種抗CD27抗體,有助于激活T細胞。 伐利尤單抗生物仿制藥-研究級該產品同種型對照:Bulk Human IgG4 Isotype Control (IB4) [ICH2257] 緩沖液:ICH3002 濃度:5mg/ml 純度:>95% by SDS-PAGE 內毒素:≤ 1.0 EU/mg as determined by the LAL method 制劑:Sterile, preservative-free, solution in PBS. BSA and Azide free.